imatinib mesylate has been researched along with Pneumothorax, Primary Spontaneous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doi, T; Fujimi, A; Huang, Y; Ishizu, A; Iwasaki, S; Kanisawa, Y; Ohta, H; Okuda, T; Sato, Y; Tanaka, S | 1 |
1 other study(ies) available for imatinib mesylate and Pneumothorax, Primary Spontaneous
Article | Year |
---|---|
[Spontaneous pneumothorax, an unusual manifestation of imatinib-resistant chronic eosinophilic leukemia: an autopsy study].
Topics: Aged; Antineoplastic Agents; Autopsy; Benzamides; Drug Resistance, Neoplasm; Fatal Outcome; Gene Fusion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Piperazines; Pneumothorax; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha | 2009 |